切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2024, Vol. 21 ›› Issue (11) : 1048 -1056. doi: 10.3877/cma.j.issn.1672-6448.2024.11.007

胸部超声影像学

多模态超声联合血清学肿瘤标志物在肺周围型病变良恶性鉴别中的应用价值
王瑞1, 陈炜2, 王金萍1,(), 李保启1   
  1. 1.230031 合肥,安徽中医药大学第一附属医院超声医学科
    2.230031 合肥,安徽中医药大学第一附属医院呼吸内科
  • 收稿日期:2024-04-06 出版日期:2024-11-01
  • 通信作者: 王金萍
  • 基金资助:
    国家青年岐黄学者支持项目;国家自然科学基金青年基金(81704060)安徽中医药大学2020年度科学研究项目(2020yfyzc49)

Value of multimodal ultrasound combined with serum tumor markers in differential diagnosis of benign and malignant peripheral pulmonary lesions

Rui Wang1, Wei Chen2, Jinping Wang1,(), Baoqi Li1   

  1. 1.Department of Ultrasound, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China
    2.Department of Respiratory, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China
  • Received:2024-04-06 Published:2024-11-01
  • Corresponding author: Jinping Wang
引用本文:

王瑞, 陈炜, 王金萍, 李保启. 多模态超声联合血清学肿瘤标志物在肺周围型病变良恶性鉴别中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1048-1056.

Rui Wang, Wei Chen, Jinping Wang, Baoqi Li. Value of multimodal ultrasound combined with serum tumor markers in differential diagnosis of benign and malignant peripheral pulmonary lesions[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(11): 1048-1056.

目的

探讨由灰阶超声、彩色多普勒超声、超声造影构成的多模态超声联合血清学肿瘤标志物组合在肺周围型病变良恶性鉴别诊断中的应用价值。

方法

回顾性分析2022年1月至2023年12月于安徽中医药大学第一附属医院行肺周围型病变超声造影检查的65例患者。按照病理结果分为良性组及恶性组,所有患者均行多模态超声检查及血清学肿瘤标志物组合检测,对获取的病灶最大径线、病灶形态、血流形态、血流信号分级、内部回声、边界、支气管征、坏死、造影剂到达病灶的始增时间(AT)、造影剂到达病灶与周围肺组织的始增时间差(TAT)、造影剂增强模式、造影剂灌注模式以及患者的血清学肿瘤标志物检测结果进行单因素分析,将单因素分析中差异有统计学意义的各因素纳入Logistic回归分析,建立肺周围型病变的多因素联合预测模型,并绘制受试者操作特征(ROC)曲线检验其诊断肺周围型病变良恶性的效能。

结果

单因素结果显示灰阶超声(病灶形态)、彩色多普勒超声(血流形态)、超声造影(AT、TAT)以及血清学肿瘤标志物组合在肺周围型病变的良恶性鉴别方面具有统计学意义(P<0.05)。Logistic回归分析显示灰阶超声(病灶形态)、彩色多普勒超声(血流形态)、超声造影(TAT)、血清学肿瘤标志物组合与肺周围型病变的良恶性显著相关,回归方程式为:Logit(P)=-6.996+0.909X病灶形态+1.521X血流形态+2.927XTAT+2.553X血清学肿瘤标志物组合。绘制灰阶超声(病灶形态)、彩色多普勒超声(血流形态)、超声造影(TAT)、血清学肿瘤标志物组合、多模态超声联合以及多模态超声联合血清学肿瘤标志物预测模型的ROC曲线,其中多模态超声联合血清学肿瘤标志物预测模型曲线下面积最大(0.904)。

结论

灰阶超声(病灶形态)、彩色多普勒超声(血流形态)、超声造影(TAT)以及血清学肿瘤标志物组合在鉴别肺周围型病变良恶性方面均具有一定的诊断价值,但多模态超声联合血清学肿瘤标志物的诊断效能更高。

Objective

To evaluate the value of multimodal ultrasound consisting of grayscale ultrasound, color Doppler flow imaging, and contrast-enhanced ultrasound (CEUS) combined with serological tumor markers in the differential diagnosis of benign and malignant peripheral pulmonary lesions.

Methods

A retrospective analysis was performed on 65 patients who underwent contrast-enhanced ultrasound examination for peripheral pulmonary lesions at the First Affiliated Hospital, Anhui University of Chinese Medicine from January 2022 to December 2023. They were divided into either a benign group or a malignant group according to the pathological results. All patients underwent multimodal ultrasound examination and detection of serological tumor markers. Lesion maximum diameter, lesion morphology, blood flow morphology, blood flow signal grade, internal echo, boundary, bronchial sign,necrosis, contrast agent arrival time (AT), the difference of arrival time between the lesion and the surrounding lung tissue (TAT), contrast agent enhancement mode, perfusion mode, and the combination of serum tumor markers were recorded for univariate analysis. All factors considered statistically significant in the univariate analysis were included in Logistic regression analysis. A multi-factor combined prediction model for peripheral pulmonary lesions was established and receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic efficiency of the model.

Results

Univariate analysis showed that there were statistically significant differences in lesion morphology on gray-scale ultrasound, blood flow morphology on Doppler flow imaging, AT and TAT on contrast-enhanced ultrasound, and the combination of serum tumor markers between benign and malignant peripheral pulmonary lesions (P<0.05). Logistic regression analysis showed that lesion morphology on gray-scale ultrasound, blood flow morphology on color Doppler flow imaging, TAT on contrast-enhanced ultrasound, and the combination of serum tumor markers were statistically significant in the differentiation of benign and malignant peripheral pulmonary lesions. The regression equation is: Logit(P)=-6.996+0.909Xlesionmorphology+1.521Xbloodflowmorphology+2.927XTAT+2.553Xthecombinationofserumtumormarkers. The ROC curves of lesion morphology on gray-scale ultrasound,blood flow morphology on color Doppler flow imaging, TAT on contrast-enhanced ultrasound, the combination of serum tumor markers, multimodal ultrasound, and multimodal ultrasound combined with serological tumor markers for the prediction of the nature of peripheral pulmonary lesions were plotted. The area under the curve of multimodal ultrasound combined with serological tumor markers was the largest (0.904).

Conclusion

Lesion morphology on gray scale ultrasound, blood flow morphology on color Doppler flow imaging, TAT on contrast-enhanced ultrasound, and the combination of serum tumor markers each have appreciated diagnostic value in differentiating benign and malignant peripulmonary lesions, but their combination has higher diagnostic efficacy.

表1 2组肺周围型病变患者基线资料比较
表2 2组肺周围型病变患者超声特征组间比较(例)
图1 男性患者,67岁,浸润性肺腺癌(低分化),右肺下叶低回声团块。图a:灰阶超声示病灶呈类圆形,边界清晰,未见支气管征,未见明显坏死;图b:彩色多普勒超声示病灶内部血流形态呈点线状,血流信号分级1级;图c:超声造影示造影剂注入11 s后,周围肺组织见造影剂进入(箭头所示);图d:超声造影示造影剂注入15 s后,病灶内可见造影剂进入(箭头所示)
图2 女性患者,55岁,肺炎,左肺下叶低回声团块,图a:灰阶超声示病灶呈楔形,边界清晰,可见支气管征,见少量坏死;图b:彩色多普勒超声示病灶内部血流形态呈点线状,血流信号分级1级;图c:超声造影示造影剂注入10 s,病灶及周围肺组织同时见造影剂进入(箭头所示);图d:超声造影示造影剂注入21 s,病灶内造影剂达峰值,整体呈不均匀高增强
表3 肺周围型病变良恶性的多因素Logistic回归分析结果
图3 Logistic回归模型预测肺周围型病变良恶性的受试者操作特征曲线
1
王慧春, 王玉斌, 崔兰兰, 等. 肺癌18F-FDG PET/CT代谢特征与肿瘤标志物的相关性[J]. 中国医学影像学杂志, 2020, 28(5): 343-348.
2
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
3
Zhang HX, Guang Y, He W, et al. Ultrasound-guided percutaneous needle biopsy skill for peripheral lung lesions and complications prevention [J]. J Thorac Dis, 2020, 12(7): 3697-3705.
4
Bi K, Zhou RR, Zhang Y, et al. US contrast agent arrival time difference ratio for benign versus malignant subpleural pulmonary lesions [J]. Radiology, 2021, 301(1): 200-210.
5
Bi K, Xia DM, Fan L, et al. Development and prospective validation of an ultrasound prediction model for the differential diagnosis of benign and malignant subpleural pulmonary lesions: a large ambispective cohort study [J]. Front Oncol, 2021, 11: 656060.
6
Piscaglia F, Nolsøe C, Dietrich C, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications [J].Ultraschall in Der Medizin, 2011, 33(1): 33-59.
7
Bai J, Yang W , Wang S, et al. Role of arrival time difference between lesions and lung tissue on contrast-enhanced sonography in the differential diagnosis of subpleural pulmonary lesions [J]. J Ultrasound Med, 2016, 35(7): 1523-1532.
8
陈霰, 徐丽伟, 邢恩芳, 等. 超声造影及介入在周围型肺部病变诊断中的价值 [J]. 中国超声医学杂志, 2015, 31(12): 1080-1082.
9
查俪晶, 闻卿, 徐雯, 等. 超声造影在局灶性机化性肺炎与原发性肺癌鉴别诊断中的价值 [J]. 中华超声影像学杂志, 2018, 27(8):688-691.
10
杨继辉, 朱灿, 沈严严, 等. 三阴性乳腺癌超声征象与P53的相关性 [J]. 中国医学影像学杂志, 2019, 27(2): 97-101.
11
韩红, 丁红, 季正标, 等. 微血流成像技术在肝肿瘤血流检测中的应用价值及与彩超的比较研究 [J]. 中国超声医学杂志, 2019, 35(4):331-334.
12
姜明, 臧爱华, 季旸, 等. 超声造影联合肺癌血清检测指标对周围型肺病变的诊断效能[J]. 中国超声医学杂志, 2021, 37(5): 520-522.
13
张怡, 毕珂, 朱惠铭, 等. 超声造影定量分析在胸膜下肺病灶良恶性鉴别中的诊断价值 [J]. 中华航海医学与高气压医学杂志, 2021,28(4): 494-498.
14
李琪, 聂芳, 杨丹, 等. 超声造影定量分析联合肿瘤标记物在肺周围型病灶良恶性诊断中的价值 [J]. 中华超声影像学杂志, 2017,26(8): 682-686.
15
Wei H, Lu Y, Ji Q, et al. The application of conventional us and transthoracic ultrasound elastography in evaluating peripheral pulmonary lesions [J]. Exp Ther Med, 2018, 16(2): 1203-1208.
16
郑小雪, 唐敏, 魏国李, 等. 常规超声、超声造影及肿瘤标志物联合评分在肺周围型病变良恶性诊断中的价值 [J]. 临床超声医学杂志, 2020, 22(3): 184-188.
17
李敏, 李海文, 陶运亮, 等. 超声造影定量参数对肺部良恶性病变鉴别诊断的价值研究[J]. 重庆医学, 2020, 49(16): 2686-2689, 2693.
18
陈松丽, 吴正华, 张诚. 实时超声造影在胸膜下肺肿块中的应用价值 [J]. 中国超声医学杂志, 2022, 38(1): 26-29.
19
Li Q, Nie F, Yang D, et al. Role of contrast-enhanced ultrasound in pulmonary lesions: 5-year experience at a single center [J]. Ultrasound Med Biol, 2021, 48(2): 257-264.
20
Wei H, Wang Y, Li J, et al. Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound [J]. Front Oncol, 2024, 14: 1352028.
21
杨瑞静, 杨一林, 阮骊韬, 等. 超声在肺周围型病变良恶性判定中的诊断价值 [J]. 临床超声医学杂志, 2012, 14(7): 454-456.
22
Gorg C. Transcutaneous contrast-enhanced sonography of pleural based pulmonary lesions [J]. Eur J Radiol, 2007, 64(2): 213-221.
23
Bai Z, Liu T, Liu W, et al. Application value of contrast-enhanced ultrasound in the diagnosis of peripheral pulmonary focal lesions [J].Medicine, 2022, 101(29): e29605.
24
唐敏, 宋建琼, 郑小雪, 等. 病灶-肺组织造影剂到达时间差对富血供肺周围型病变的诊断价值 [J]. 中国超声医学杂志, 2019,35(10): 894-897.
25
Tang M, Xie Q, Wang J, et al. Time difference of arrival on contrastenhanced ultrasound in distinguishing benign inflammation from malignant peripheral pulmonary lesions [J]. Front Oncol, 2020, 10:578884.
26
李倩倩, 薛洁, 姜静. 超声造影结合肿瘤标记物对肺周围型占位性病变性质的诊断效果研究 [J]. 湖南师范大学学报(医学版), 2020,17(1): 165-168.
27
吴霞玲, 孟娜, 黄星月, 等. 超声造影时间-强度曲线在肺周围性病变及胸腺肿瘤诊断中的应用价值 [J]. 武汉大学学报(医学版),2015, 36(3): 6.
28
Shen M, Bi K, Cong Y, et al. Application of contrast-enhanced ultrasound in the differential diagnosis of benign and malignant subpleural pulmonary lesions [J]. J Ultrasound Med, 2022, 41(5):1147-1157.
29
王凇. 新型超声造影微血管灌注模式对周围型肺占位的鉴别诊断[J]. 中华超声影像学杂志, 2014, 23(5): 408-413.
30
唐敏, 宋建琼, 郑小雪, 等. 富血供肺周围型病变的超声造影实时分析 [J]. 中国超声医学杂志, 2019, 35(9): 776-779.
31
梁汝娜, 王娟, 张伟, 等. 超声造影与高分辨率CT鉴别诊断周围型肺肿物的价值 [J].中国CT和MRI杂志, 2023, 21(3): 68-70.
32
陈倩倩, 宋佳, 孙淑艳. 五种肿瘤标志物联合检测在肺癌诊断中的价值 [J]. 中国老年学杂志, 2018, 38(7): 1597-1598.
33
张婷, 向波, 林勇平. 肿瘤标志物联合检测在肺癌辅助诊断中的预测价值 [J]. 中华预防医学杂志, 2021, 55(6): 786-791.
34
陈俊峰. 彩色多普勒超声及肿瘤标志物联合诊断肺周围型占位病变的价值分析 [J]. 中国医疗器械信息, 2023, 29(10): 10-12, 23.
35
万里, 赵岭. 病变-肺组织始增时间差联合血清肿瘤标记物对肺周围型病变的诊断价值 [J]. 中华超声影像学杂志, 2021, 30(11): 950-954.
[1] 刘源鑫, 何丽莉, 孙颖华. 儿童排泄性尿路超声造影改良方法的初步探讨[J/OL]. 中华医学超声杂志(电子版), 2024, 21(12): 1111-1117.
[2] 汪洪斌, 张红霞, 何文, 杜丽娟, 程令刚, 张雨康, 张萌. 低级别阑尾黏液性肿瘤与阑尾黏液腺癌超声及超声造影特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 865-871.
[3] 宋勇, 李东炫, 王翔, 李锐. 基于数据挖掘法分析3 种超声造影剂不良反应信号[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 890-898.
[4] 王博冉, 乔春梅, 李春歌, 王欣, 王晓磊. 超声造影评估类风湿关节炎亚临床滑膜炎疾病进展的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 802-808.
[5] 马晓菊, 梁潇, 段云友, 袁丽君, 赵萍. NBAV脂质纳泡对ApoE -/-小鼠动脉粥样硬化病变的评估和干预[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 608-616.
[6] 罗敏华, 王文平, 孔文韬. 肝脏炎性假瘤的超声造影表现及其诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(03): 297-303.
[7] 谭雷, 王等娣, 张浩, 丹增卓玛, 龙怡, 吴泽倩. 超声造影在肝破裂诊断中的应用:一例西藏地区肝破裂引发的思考[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 113-117.
[8] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[9] 张红君, 郑博文, 廖梅, 任杰. 超声及超声造影在肝移植术后上腹部淋巴结良恶性鉴别诊断中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 562-567.
[10] 温绍敏, 王雅晳, 施依璐, 段莎莎, 云书荣, 张小杉. 靶向超声造影技术在动脉粥样硬化治疗中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 496-499.
[11] 卫星彤, 李昊昌, 赵欣. 甲状腺木乃伊结节于多模态超声下的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 415-419.
[12] 黄宏山, 陈成彩. 经淋巴管超声造影在乳腺癌前哨淋巴结诊断中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 411-414.
[13] 赵欣, 李昊昌, 卫星彤. 多模态超声在非肿块型乳腺病变中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 407-410.
[14] 曹建辉, 冯斌, 黄伟伟, 张超. 超声造影在乳腺BI-RADS 4A类结节诊断及穿刺活检中的应用价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 363-368.
[15] 史宛瑞, 崔立刚. 颈动脉一过性血管周围炎综合征的影像学诊断研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 516-519.
阅读次数
全文


摘要